NO20001200D0 - Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase - Google Patents
Pyrrolopyrrolonderivater som inhibitorer av neurofil elastaseInfo
- Publication number
- NO20001200D0 NO20001200D0 NO20001200A NO20001200A NO20001200D0 NO 20001200 D0 NO20001200 D0 NO 20001200D0 NO 20001200 A NO20001200 A NO 20001200A NO 20001200 A NO20001200 A NO 20001200A NO 20001200 D0 NO20001200 D0 NO 20001200D0
- Authority
- NO
- Norway
- Prior art keywords
- neurophilic
- elastase
- inhibitors
- pyrrolopyrrolone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9719187.8A GB9719187D0 (en) | 1997-09-09 | 1997-09-09 | Compounds |
| PCT/EP1998/005604 WO1999012931A1 (en) | 1997-09-09 | 1998-09-07 | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001200D0 true NO20001200D0 (no) | 2000-03-08 |
| NO20001200L NO20001200L (no) | 2000-05-08 |
Family
ID=10818820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001200A NO20001200L (no) | 1997-09-09 | 2000-03-08 | Pyrrolopyrrolonderivater som inhibitorer av nøyrofil elastase |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6228853B1 (no) |
| EP (1) | EP1019406A1 (no) |
| JP (1) | JP2001515902A (no) |
| KR (1) | KR20010023830A (no) |
| CN (1) | CN1278821A (no) |
| AP (1) | AP2000001760A0 (no) |
| AU (1) | AU9536098A (no) |
| BR (1) | BR9811651A (no) |
| CA (1) | CA2303249A1 (no) |
| EA (1) | EA200000205A1 (no) |
| EE (1) | EE200000137A (no) |
| GB (1) | GB9719187D0 (no) |
| HR (1) | HRP20000136A2 (no) |
| HU (1) | HUP0003475A3 (no) |
| ID (1) | ID24364A (no) |
| IL (1) | IL134935A0 (no) |
| IS (1) | IS5394A (no) |
| MA (1) | MA26544A1 (no) |
| NO (1) | NO20001200L (no) |
| PL (1) | PL339186A1 (no) |
| SK (1) | SK3242000A3 (no) |
| TR (1) | TR200001026T2 (no) |
| WO (1) | WO1999012931A1 (no) |
| ZA (1) | ZA988162B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2805818B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant |
| US7745226B2 (en) * | 2005-04-06 | 2010-06-29 | Quest Diagnostics Investments Incorporated | Methods for detecting vitamin D metabolites |
| US7972868B2 (en) | 2007-11-28 | 2011-07-05 | Quest Diagnostics Investments Incorporated | Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry |
| US7977117B2 (en) | 2009-12-03 | 2011-07-12 | Quest Diagnostics Investments Incorprated | Vitamin D metabolite determination utilizing mass spectrometry following derivatization |
| US20110240840A1 (en) | 2009-12-11 | 2011-10-06 | Quest Diagnostics Investments Incorporated | Mass spectrometric determination of cookson-derivatized, non-metabolized vitamin d |
| EP3693734A3 (en) | 2009-12-11 | 2020-12-23 | Quest Diagnostics Investments Incorporated | Mass spectrometry of steroidal compounds in multiplex samples |
| US20220354833A1 (en) | 2019-09-17 | 2022-11-10 | Mereo Biopharma 4 Limited | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
| WO2021209739A1 (en) | 2020-04-16 | 2021-10-21 | Mereo Biopharma 4 Limited | Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency |
| TW202325294A (zh) | 2021-10-20 | 2023-07-01 | 英商梅瑞奧生物製藥４有限公司 | 用於治療纖維化之嗜中性球彈性蛋白酶抑制劑 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3983245A (en) | 1975-02-06 | 1976-09-28 | Smithkline Corporation | Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes |
| GB8512230D0 (en) * | 1985-05-14 | 1985-06-19 | Shell Internationale Researche | Preparation of carboxylic acid salt |
| GB9211783D0 (en) | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
| GB9402680D0 (en) * | 1994-02-11 | 1994-04-06 | Zeneca Ltd | Pyrrolidine derivatives |
| CA2240467A1 (en) | 1996-01-03 | 1997-07-17 | Smithkline Beecham P.L.C. | Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| ATE261969T1 (de) * | 1996-03-28 | 2004-04-15 | Glaxo Group Ltd | Pyrrolopyrrolone als inhibitoren von neutrophiler elastase |
-
1997
- 1997-09-09 GB GBGB9719187.8A patent/GB9719187D0/en not_active Ceased
-
1998
- 1998-09-07 BR BR9811651-7A patent/BR9811651A/pt not_active Application Discontinuation
- 1998-09-07 SK SK324-2000A patent/SK3242000A3/sk unknown
- 1998-09-07 HU HU0003475A patent/HUP0003475A3/hu unknown
- 1998-09-07 JP JP2000510738A patent/JP2001515902A/ja active Pending
- 1998-09-07 EA EA200000205A patent/EA200000205A1/ru unknown
- 1998-09-07 KR KR1020007002505A patent/KR20010023830A/ko not_active Application Discontinuation
- 1998-09-07 AU AU95360/98A patent/AU9536098A/en not_active Abandoned
- 1998-09-07 MA MA25244A patent/MA26544A1/fr unknown
- 1998-09-07 WO PCT/EP1998/005604 patent/WO1999012931A1/en not_active Application Discontinuation
- 1998-09-07 CN CN98810967A patent/CN1278821A/zh active Pending
- 1998-09-07 ZA ZA9808162A patent/ZA988162B/xx unknown
- 1998-09-07 EE EEP200000137A patent/EE200000137A/xx unknown
- 1998-09-07 TR TR2000/01026T patent/TR200001026T2/xx unknown
- 1998-09-07 US US09/508,326 patent/US6228853B1/en not_active Expired - Fee Related
- 1998-09-07 CA CA002303249A patent/CA2303249A1/en not_active Abandoned
- 1998-09-07 ID IDW20000665A patent/ID24364A/id unknown
- 1998-09-07 AP APAP/P/2000/001760A patent/AP2000001760A0/en unknown
- 1998-09-07 PL PL98339186A patent/PL339186A1/xx not_active Application Discontinuation
- 1998-09-07 EP EP98948905A patent/EP1019406A1/en not_active Withdrawn
- 1998-09-07 IL IL13493598A patent/IL134935A0/xx unknown
-
2000
- 2000-03-03 IS IS5394A patent/IS5394A/is unknown
- 2000-03-08 NO NO20001200A patent/NO20001200L/no not_active Application Discontinuation
- 2000-03-09 HR HR20000136A patent/HRP20000136A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9719187D0 (en) | 1997-11-12 |
| US6228853B1 (en) | 2001-05-08 |
| AU9536098A (en) | 1999-03-29 |
| SK3242000A3 (en) | 2001-03-12 |
| CA2303249A1 (en) | 1999-03-18 |
| EE200000137A (et) | 2001-02-15 |
| NO20001200L (no) | 2000-05-08 |
| ZA988162B (en) | 2000-03-22 |
| ID24364A (id) | 2000-07-13 |
| IL134935A0 (en) | 2001-05-20 |
| PL339186A1 (en) | 2000-12-04 |
| EA200000205A1 (ru) | 2000-10-30 |
| CN1278821A (zh) | 2001-01-03 |
| HRP20000136A2 (en) | 2000-08-31 |
| HUP0003475A2 (hu) | 2001-09-28 |
| IS5394A (is) | 2000-03-03 |
| AP2000001760A0 (en) | 2000-03-31 |
| TR200001026T2 (tr) | 2000-09-21 |
| WO1999012931A1 (en) | 1999-03-18 |
| MA26544A1 (fr) | 2004-12-20 |
| JP2001515902A (ja) | 2001-09-25 |
| EP1019406A1 (en) | 2000-07-19 |
| KR20010023830A (ko) | 2001-03-26 |
| HUP0003475A3 (en) | 2002-01-28 |
| BR9811651A (pt) | 2000-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012984D0 (no) | Succinoylamino benzodiazepiner som inhibitorer av AB proteinproduksjon | |
| NO984727D0 (no) | Substituerte benzensulfonamid derivater som promedikamenter av COX-2 inhibitorer | |
| NO20003057L (no) | Indolderivater som inhibitorer av faktor Xa | |
| NO992725L (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
| NO984917L (no) | Ureaderivater som inhibitorer av IMPDH-enzym | |
| FI944804A0 (fi) | Pyrimidinyyliasetamideja elastaasin estäjinä | |
| DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
| NO986090D0 (no) | Fenylalaninderivater som integrininhibitorer | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| NO20001955D0 (no) | Substituerte 4-amino-tiazol-2-yl forbindelser som inhibitorer av cyclinavhengige kinaser | |
| DK0891362T3 (da) | Pyrrolopyrrolon derivater som inhibitorer for neutrofil elastase | |
| NO20010322D0 (no) | Heterocykliske forbindelser som inhibitorer av rotamaseenzymer | |
| NO20010331D0 (no) | Ftalazinderivater som fosfodiesterase 4-inhibitorer | |
| EE200000138A (et) | Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena | |
| NO991316L (no) | 3-merkaptoacetylamino-1,5-substituerte-2-okso-azepanderivater som er anvendbare som inhibitorer av matriksmetalloproteinase | |
| NO20001200D0 (no) | Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase | |
| NO20005301D0 (no) | Pyrrolidiner som inhibitorer av neuraminidaser | |
| ATE221065T1 (de) | Amidinderivate als inhibitoren von no-synthase | |
| NO20015033D0 (no) | Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| FI971590A0 (fi) | Anordning foer foerdelning av inluft till rumsutrymmen som skall luftkonditioneras | |
| EE9900585A (et) | 6-asauratsiili derivaadid IL-5 inhibiitoritena | |
| FI980053A0 (fi) | Anordning foer utformande av fiberbollar av laongstraeckta fibrer som foeljer med enluftstroem | |
| NO20000860D0 (no) | Syklopeptidderivater som adhesjonsinhibitorer | |
| NO965353D0 (no) | 3-amino-2-okso-1-piperidineddiksyrederivater som enzyminhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |